May 08, 2019 8:30am EDT Veru to Report Fiscal 2019 Second-Quarter Financial Results; Host Conference Call on May 15th
Feb 12, 2019 8:00am EST Veru Announces Scientific Presentations for Novel Prostate Cancer Drug Candidates at the 2019 American Society of Clinical Oncology Genitourinary Cancers Symposium
Feb 06, 2019 8:30am EST Veru to Report Fiscal 2019 First-Quarter Financial Results, Host Conference Call on February 13th
Jan 22, 2019 8:30am EST Veru Initiates Clinical Trial for Proprietary, Novel, First-in-Class Drug for Advanced Prostate Cancer
Jan 15, 2019 8:00am EST Veru Announces Acceptance of Four Abstracts for Presentation at the Genitourinary Cancer Symposium in February 2019
Jan 14, 2019 8:00am EST Veru Announces Successful Bioavailability and Bioequivalence Clinical Trial for Tadalafil and Finasteride Combination Tablet for Benign Prostatic Hyperplasia
Dec 13, 2018 6:30am EST Veru Reports Strong Net Revenues and Gross Profit for Fiscal 2018 Fourth-Quarter
